Conditions: Cataract
Allocation: RANDOMIZED | Intervention model: FACTORIAL
Enrollment: 223
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether the use of OMS302 (the study drug) in individuals undergoing Cataract Extraction with Lens Replacement (CELR) surgery is safe and effective at maintaining an adequately dilated pupil during surgery and reducing post-operative symptoms of discomfort (such as eye pain and irritation).

Detailed description:

Arms:
arm 1: OMS302 Solution arm 2: OMS302 Mydriatic Solution arm 3: OMS302 Anti-inflammatory Solution arm 4: Balanced Salt Solution (BSS) Solution

Interventions: intervention 1: OMS302 Solution intervention 2: OMS302 Mydriatic Solution intervention 3: OMS302 Anti-inflammatory Solution intervention 4: Balanced Salt Solution (BSS) Solution
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None intervention 4: None

Protocol document: